 HYDERABAD, India PRINCETON, N.J.--BUSINESS WIRE--Dr. Reddys Laboratories Ltd. BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as Dr. Reddys today announced the launch of Ertapenem for Injection, 1 gvial, a therapeutic equivalent generic version of INVANZ ertapenem for injection for injection, 1 gvial approved by the U.S. Food and Drug Administration USFDA. We are pleased to bring this important product to market at this t 